porcin
reproduct
respiratori
syndrom
prr
one
challeng
subject
research
veterinari
viral
immunolog
immun
respons
prr
viru
prrsv
still
poorli
understood
infect
pig
develop
strong
rapid
humor
respons
initi
antibodi
confer
protect
even
harm
mediat
antibodydepend
enhanc
diseas
contrast
develop
neutralis
antibodi
na
delay
gener
cellmedi
immun
respons
prrsvspecif
interferon
ifn
c
secret
cell
initi
errat
spite
induct
strong
rapid
na
ifnc
respons
seem
requir
effect
vaccin
prrsv
strongli
modul
host
immun
respons
viru
inhibit
key
cytokin
ifna
may
induc
regulatori
cytokin
interleukin
il
develop
na
seem
impair
exist
decoy
epitop
close
main
neutralis
epitop
glycoprotein
abil
modul
host
immun
respons
probabl
vari
among
strain
isol
genet
divers
viru
high
shown
divers
seriou
implic
develop
vaccin
sinc
immun
induc
one
strain
may
partial
differ
strain
even
within
genotyp
panorama
develop
newer
univers
efficaci
prrsv
vaccin
challeng
present
state
knowledg
allow
optim
collabor
effort
undertaken
scientif
commun
year
emerg
porcin
reproduct
respiratori
syndrom
prr
understand
diseas
still
far
complet
clinic
featur
prr
well
known
global
pictur
epidemiolog
drawn
although
gap
remain
fill
manag
husbandri
procedur
devis
control
diseas
vaccin
avail
howev
infect
prr
viru
prrsv
still
widespread
viru
frequent
reintroduc
farm
erad
reason
failur
answer
simpl
examin
scientif
literatur
problem
report
pig
veterinarian
indic
vaccin
use
tool
although
efficaci
far
univers
complet
approach
let
take
strain
let
attenu
inactiv
vaccin
gener
suffici
immun
protect
diseas
valid
prrsv
present
review
discuss
known
gap
remain
understand
prrsv
immun
immunopathogenesi
conclud
posit
messag
current
avail
inform
allow
us
identifi
crucial
point
need
studi
order
understand
diseas
overcom
challeng
prrsv
immunolog
adapt
immun
respons
prrsv
develop
adapt
immun
prrsv
tale
unusu
featur
humor
cellular
compon
immun
respons
circul
antibodi
prrsv
detect
pig
day
postinfect
pi
anim
seroconvert
day
pi
yoon
et
al
yoon
et
al
prrsvspecif
immunoglobulin
igm
reach
peak
day
pi
declin
undetect
level
day
pi
concentr
igg
reach
maximum
day
pi
vezina
et
al
loemba
et
al
howev
rapid
igm
igg
respons
correspond
neutralis
antibodi
na
yoon
et
al
nelson
et
al
studi
kinet
humor
respons
pig
american
strain
prrsv
earliest
antibodi
direct
kda
nucleoprotein
follow
kda
protein
kda
glycoprotein
studi
show
nonstructur
protein
contain
cluster
nonneutralis
bepitop
probabl
immunodomin
protein
prrsv
oleksiewicz
et
al
de
lima
et
al
diagnost
test
detect
antibodi
mainli
n
protein
antibodi
appear
around
first
week
pi
persist
sever
month
correl
protect
na
detect
convent
viru
neutralis
test
vnt
first
week
pi
addit
fresh
complement
prolong
incub
virusserum
mixtur
increas
sensit
vnt
allow
detect
na
earlier
day
pi
takikawa
et
al
author
show
complement
may
increas
vnt
titr
one
dilut
diaz
et
al
diaz
et
al
sinc
addit
significantli
reduc
sensit
modifi
vnt
like
low
level
neutralis
igm
appear
earli
phase
infect
takikawa
et
al
howev
even
modifi
vnt
na
titr
still
rel
low
day
pi
na
consist
detect
day
pi
later
european
americantyp
strain
prrsv
yoon
et
al
meier
et
al
diaz
et
al
na
mainli
direct
contain
major
neutralis
epitop
nelson
et
al
dea
gonin
et
al
claim
protein
also
contain
neutralis
epitop
meulenberg
et
al
gonin
et
al
weiland
et
al
yang
et
al
canceltirado
et
al
one
report
suggest
also
contain
neutralis
epitop
canceltirado
et
al
howev
protein
seem
minor
biolog
signific
compar
earli
develop
nonna
may
signific
effect
develop
prr
shown
nonna
enhanc
viral
replic
alveolar
macrophag
phenomenon
known
antibodydepend
enhanc
ade
yoon
et
al
yoon
et
al
target
antibodi
n
protein
yoon
et
al
canceltirado
et
al
nonneutralis
humor
respons
may
act
trojan
hors
prrsv
coat
viru
enhanc
internalis
viral
particl
macrophag
question
na
develop
earli
nonna
na
may
play
import
role
although
import
may
differ
natur
infect
compar
vaccin
vezina
et
al
report
isol
prrsv
blood
pig
na
follow
experiment
infect
viraemia
may
resolv
without
detect
level
neutralis
antibodi
diaz
et
al
similar
relat
viru
lactat
dehydrogenas
viru
ldv
dynam
prrsvsuscept
macrophag
may
govern
level
viraemia
diaz
et
al
cytolysi
apoptosi
exhaust
suscept
macrophag
infect
confin
macrophagerich
organ
lymph
node
hypothesi
na
may
requir
resolut
viraemia
infect
differ
pictur
aris
protect
infect
consid
na
block
prrsv
infect
macrophag
vitro
delputt
et
al
transfer
na
pregnant
sow
na
titr
protect
reproduct
failur
block
transplacent
infect
use
antibodi
transfer
system
titr
higher
protect
piglet
develop
viraemia
wherea
sterilis
immun
attain
na
titr
lopez
et
al
result
suggest
vaccin
capabl
induc
na
titr
prevent
clinic
diseas
key
tool
erad
prrsv
cellmedi
immun
cmi
also
extrem
import
prr
earli
studi
show
pig
recov
experiment
prrsv
infect
strong
lymphocyt
prolif
respons
although
respons
detect
four
week
pi
parallel
na
respons
bautista
molitor
lopez
fuert
et
al
cytokin
respons
mainli
interferon
ifn
c
lesser
extent
lopez
fuert
et
al
vaccin
modifi
live
vaccin
use
american
strain
prrsv
virusspecif
ifnc
secret
cell
first
appear
third
week
postvaccin
fluctuat
errat
per
million
peripher
blood
mononuclear
cell
pbmc
next
ten
week
increas
per
million
pbmc
week
postvaccin
meier
et
al
ifnc
secret
cell
mainli
cell
small
proport
cytotox
cell
similar
delay
develop
prrsvspecif
ifnc
secret
cell
evid
infect
vaccin
european
strain
prrsv
diaz
et
al
diaz
et
al
contrast
ifnc
secret
cell
per
million
pbmc
evid
week
vaccin
aujeszki
diseas
viru
meier
et
al
unusu
characterist
adapt
immun
respons
prrsv
suggest
viru
strongli
modul
immun
respons
earli
studi
show
prrsv
highli
suscept
action
type
ifn
suggest
viru
abl
inhibit
ifna
respons
sinc
cytokin
could
detect
lung
pig
prrsv
activ
replic
albina
et
al
buddaert
et
al
ifna
level
lung
prrsvinfect
pig
much
lower
lung
pig
infect
porcin
coronaviru
swine
influenza
viru
van
reeth
et
al
frequenc
virusspecif
ifnc
secret
cell
correl
frequenc
ifna
secret
cell
pig
infect
prrsv
royae
et
al
although
exact
mechan
prrsv
inhibit
ifna
unknown
involv
inhibit
nuclear
factor
nf
j
b
pathway
lee
kleiboek
differ
prrsv
isol
differ
plaqu
clone
strain
differ
abil
induc
inhibit
ifna
lee
et
al
preliminari
result
indic
differ
european
prrsv
isol
differ
abil
induc
ifna
also
tnfa
alveolar
macrophag
dendrit
cell
unpublish
observ
impair
ifna
secret
would
expect
affect
develop
effect
helper
type
immun
respons
cytokin
may
import
role
regul
immun
respons
prrsv
infect
either
european
american
strain
prrsv
level
mrna
increas
porcin
pbmc
concentr
increas
bronchoalveolar
lavag
bal
fluid
thanawongnuwech
et
al
european
strain
prrsv
induc
strong
respons
pbmc
pig
suggest
memori
featur
diaz
et
al
pig
vaccin
strain
lower
frequenc
prrsvspecif
ifnc
secret
cell
anim
vaccin
induc
strain
diaz
et
al
monocyt
appear
major
sourc
prrsv
infect
charerntantanakul
et
al
prrsv
also
appear
induc
asai
et
al
sipo
et
al
wherea
role
transform
growth
factorb
prrsv
infect
unclear
royae
et
al
prrsv
may
interfer
correct
antigen
present
activ
lymphocyt
prrsv
downregul
express
major
histocompat
complex
mhc
dendrit
cell
dc
although
correl
impair
prolif
respons
mix
leucocyt
reaction
love
et
al
express
mhci
mhcii
well
downregul
monocytederiv
dc
stimul
infecti
inactiv
prrsv
wang
et
al
studi
prolif
respons
decreas
infect
dc
use
syngen
allogen
lymphocyt
suggest
infect
dc
present
antigen
less
effici
wang
et
al
prrsv
may
downregul
innat
immun
respons
alter
cytokin
pattern
macrophag
dendrit
cell
well
modifi
express
molecul
involv
antigen
present
discuss
previous
one
intrigu
featur
prrsv
infect
delay
develop
na
main
neutralis
epitop
prrsv
design
epitop
b
locat
ntermin
ectodomain
amino
acid
american
european
strain
ostrowski
et
al
plagemann
et
al
wissink
et
al
plagemann
neutralis
epitop
flank
glycosyl
site
addit
immunodomin
epitop
design
epitop
locat
ntermin
ectodomain
amino
acid
characterist
decoy
epitop
similar
human
immunodefici
viru
type
ostrowski
et
al
decoy
epitop
may
interfer
immun
respons
main
neutralis
epitop
b
result
delay
na
respons
insert
pandr
helper
cell
epitop
epitop
b
decoy
epitop
increas
immunogen
epitop
b
mice
fang
et
al
suggest
proxim
epitop
b
import
delay
na
respons
decoy
epitop
way
prrsv
evad
humor
immun
respons
main
target
na
contain
four
glycosyl
site
locat
close
neutralis
epitop
american
field
strain
prrsv
lack
glycosyl
site
upstream
hypervari
region
induc
na
rapidli
strongli
infect
pig
strain
lack
downstream
glycosyl
site
posit
even
though
strain
equal
suscept
na
faaberg
et
al
spanish
prrsv
strain
evolv
trend
lose
glycosyl
site
equival
american
strain
maintain
gain
glycosyl
flank
region
consist
select
strain
induc
weaker
na
respons
mateu
et
al
prrsv
divid
european
type
american
type
ii
genotyp
four
subtyp
identifi
within
european
genotyp
stadejek
et
al
divers
within
genotyp
subtyp
high
forsberg
et
al
stadejek
et
al
larochel
et
al
mateu
et
al
stadejek
et
al
furthermor
prrsv
also
demonstr
phenomenon
quasispeci
gener
rowland
et
al
goldberg
et
al
impact
genet
divers
prrsv
upon
immun
respons
protect
afford
vaccin
prr
emerg
europ
america
almost
simultan
first
vaccin
prrsv
market
intern
modifi
live
vaccin
deriv
prototyp
american
strain
time
obviou
genet
divers
prrsv
could
pose
problem
regard
efficaci
vaccin
particularli
infect
european
genotyp
pregnant
gilt
infect
american
isol
challeng
european
isol
lelystad
viru
lv
late
gestat
partial
protect
transplacent
infect
viru
cross
placenta
gilt
wherea
gilt
challeng
homolog
viru
fulli
protect
lager
et
al
result
show
heterolog
protect
exist
partial
suggest
common
epitop
like
involv
protect
european
americantyp
strain
furthermor
monoclon
antibodi
neutralis
epitop
relat
viru
ldv
abl
neutralis
lv
indic
neutralis
epitop
share
extent
divers
arterivirus
plagemann
et
al
although
partial
heterolog
protect
might
benefici
circumst
genotypebas
vaccin
insuffici
produc
immunis
steril
given
genet
divers
viru
within
one
genotyp
question
whether
phenomenon
might
influenc
efficaci
homolog
vaccin
piglet
vaccin
attenu
version
american
strain
challeng
day
later
mixtur
virul
version
strain
mengel
et
al
given
virul
strain
present
challeng
piglet
previous
receiv
attenu
version
strain
wherea
infect
virul
strain
establish
indic
immun
prrsv
may
strainrel
vaccin
europeantyp
modifi
live
vaccin
pig
mostli
neg
viru
serum
bal
fluid
challeng
lv
labarqu
et
al
contrast
vaccin
pig
develop
viraemia
day
posit
viru
bal
fluid
challeng
italian
variant
strain
similar
vaccin
strain
protect
prrsv
infect
strain
differ
one
use
vaccin
somewhat
complex
matter
genet
similar
pig
vaccin
two
differ
europeantyp
vaccin
challeng
strain
similar
one
vaccin
slightli
differ
similar
diaz
et
al
surprisingli
heterolog
vaccin
afford
sterilis
immun
homolog
vaccin
vaccin
induc
higher
level
ifnc
secret
cell
wherea
induc
releas
pmbc
abil
strain
induc
strong
cellmedi
immun
respons
import
genet
similar
induc
protect
complex
immun
respons
prrsv
abil
viru
escap
modul
host
immun
system
make
difficult
develop
vaccin
use
erad
diseas
vaccin
accomplish
least
four
requir
efficaci
univers
safeti
abil
differenti
vaccin
infect
anim
first
line
investig
detail
investig
b
cell
epitop
involv
develop
protect
immun
neutralis
epitop
establish
definit
littl
known
regard
cell
epitop
although
cell
respons
individu
prrsv
polypeptid
report
virusinfect
anim
bautista
et
al
common
critic
epitop
european
american
strain
prrsv
clearli
identifi
support
develop
univers
vaccin
second
line
research
determin
compon
virion
viral
genom
involv
downregul
modul
host
immun
system
mechan
occur
critic
develop
live
attenu
vaccin
efficaci
given
vaccin
relat
immunolog
properti
also
characterist
challeng
strain
therefor
studi
relationship
genet
divers
immunopatholog
properti
differ
strain
need
revers
genet
characteris
modul
properti
extens
set
strain
necessari
achiev
seriou
intern
collabor
effort
thirdli
develop
vaccin
safe
mean
possibl
revers
virul
elimin
transmiss
vaccin
strain
pig
minim
nonexist
one
obviou
way
gain
safeti
use
nonrepl
vaccin
howev
unclear
nonrepl
vaccin
abl
induc
na
adequ
cellmedi
immun
respons
zuckermann
et
al
research
subunit
vectorbas
vaccin
adjuv
undertaken
fourthli
develop
differenti
vaccin
highli
desir
sinc
prrsv
viru
rel
small
genom
difficult
find
target
delet
although
knowledg
extens
studi
essenti
nonessenti
part
viral
genom
perform
occurr
natur
variant
small
delet
indic
nonstructur
protein
could
target
construct
differenti
vaccin
fang
et
al
necessari
demonstr
vaccin
protect
infect
challeng
experi
one
strain
differ
genotyp
also
differ
strain
within
given
genotyp
tabl
summaris
knowledg
alreadi
known
requir
develop
newer
vaccin
number
import
question
remain
solv
prr
immunolog
consider
exampl
develop
adapt
immun
respons
infect
prrsv
vaccin
anomal
ifnc
secret
cell
appear
late
evolv
errat
first
week
infect
na
respons
also
delay
na
may
protect
diseas
present
suffici
quantiti
infect
seem
essenti
clear
viru
blood
cours
infect
prrsv
abl
modul
innat
respons
probabl
regul
ifna
respons
two
differ
prrsv
genotyp
exist
evolv
parallel
cross
protect
afford
genotyp
partial
genet
divers
within
genotyp
high
enough
allow
vaccin
anim
reinfect
differ
strain
genotyp
circumst
creat
difficulti
understand
immun
system
viru
interact
possibl
differ
prrsv
strain
abl
modul
regul
immun
system
differ
way
therefor
publish
experi
alway
interpret
caution
particularli
tri
extract
gener
principl
particular
experi
collabor
research
best
way
enhanc
understand
prrsv
immunolog
contribut
better
understand
prr
structur
protein
seem
mainli
essenti
nonstructur
protein
might
nonessenti
exact
map
essenti
nonessenti
protein
nonstructur
protein
may
suffer
natur
delet
structur
protein
north
american
strain
porcin
reproduct
respiratori
syndrom
viru
virolog
delputt
pl
meert
p
coster
nauwynck
hj
effect
virusspecif
antibodi
attach
intern
infect
porcin
reproduct
respiratori
syndrom
viru
primari
macrophag
veterinari
immunolog
immunopatholog
diaz
darwich
l
pappaterra
g
pujol
j
mateu
e
